NCT01928498View on ClinicalTrials.gov

Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 13, 2020

Study Completion Date

August 27, 2020

Conditions
Arteriovenous FistulaeArteriovenous Graft
Interventions
DEVICE

Paclitaxel Eluting Balloon Angioplasty

DEVICE

Percutaneous Transluminal Angioplasty (PTA)

Trial Locations (3)

Unknown

Hôpital Charles-Lemoyne, Longueuil

H1T 2M4

Hôpital Maisonneuve-Rosemont, Montreal

H2L 4M1

Centre Hospitalier de l'université de Montréal-CHUM, Montreal

All Listed Sponsors
collaborator

Biotronik Canada Inc

INDUSTRY

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT01928498 - Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis | Biotech Hunter | Biotech Hunter